Skip to Main Content

Paper Details

The Changing Landscape of Systemic Treatment for Cervical Cancer: Rationale for Inhibition of the TGF-β and PD-L1 Pathways.
Front Oncol
8
2022
Bintrafusp alfa, Cervical Cancer, Cervical cancer, HPV, PD-(L)1, PD-L1, RII receptor, TGF-, TGF-?, advanced cervical cancer, cancer, cancer cells, cancers, cervical cancer, human, human immunoglobulin G1 monoclonal antibody, human papillomavirus, normal cervical cells, patients, women
Author NameAffiliation
Michael J BirrerWinthrop P. Rockefeller Cancer Institute, University of Arkansas Medical School
Isabelle Ray-CoquardUniversity Claude Bernard Lyon
  • 1 - 2

Datasets

Release 1.2